Testing effectiveness (Phase 2)Study completedNCT01022346
What this trial is testing
RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection
Who this might be right for
Cervical Intraepithelial Neoplasia
Hoffmann-La Roche 206